Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

TPEX/4129 stock hub

TPEX/4129 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4129is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

9.6B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4129

In the news

Latest news · TPEX/4129

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.3

P25 12P50 15.5P75 22.5

Trailing P/E17.6

P25 14.4P50 18P75 31.9

ROE14

P25 -16.2P50 0.3P75 9.8

ROIC10.2

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4129 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

239

Groups with data

Currency

TWD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 11.1B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Medical Devices
Isin	TW0004129002
Last refreshed	2026-05-10
Market cap	TWD 9.6B
Price	TWD 99.7
Price currency	TWD
Sector	Healthcare
Sic	3842
Symbol	tpex/4129
Website	https://www.unitedorthopedic.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.85%
EV Earnings	19.78x
EV/EBIT	16.48x
EV/EBITDA	9.22x
EV/FCF	32.82x
EV/Sales	1.97x
FCF yield	3.52%
Forward P/E	14.29x
P/B ratio	2.29x
P/E ratio	17.58x
P/S ratio	1.7x
PE Ratio10 Y	38.29x
PE Ratio3 Y	19.33x
PE Ratio5 Y	26.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.1%
EBITDA Margin	21.83%
FCF margin	5.99%
Gross margin	77.79%
Gross Profit	TWD 4.4B
Gross Profit Growth	21.46%
Gross Profit Growth Q	18.42%
Gross Profit Growth3 Y	23.02%
Gross Profit Growth5 Y	21.79%
Net Income	TWD 562M
Net Income Growth	23.24%
Net Income Growth Q	7.31%
Net Income Growth Quarters	2%
Net Income Growth Years	4%
Net Income Growth3 Y	36.39%
Net Income Growth5 Y	48.27%
Pretax Margin	13.37%
Profit Margin	9.95%
Profitable Years	10
ROA	6.23
Roa5y	4.67
ROCE	13.92
ROE	14.02
Roe5y	9.45
ROIC	10.17
Roic5y	7.69

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	6.22%
Cagr15y	7.08%
Cagr1y	21.27%
Cagr20y	13.91%
Cagr3y	21.77%
Cagr5y	26.73%
Div CAGR10	9.6%
Div CAGR3	20.69%
Div CAGR5	36.73%
EPS Growth	19.62
EPS Growth Q	2.48
EPS Growth Quarters	2
EPS Growth Years	4
EPS Growth3 Y	31.21
EPS Growth5 Y	43.33
FCF Growth	75.53%
FCF Growth3 Y	84.81%
FCF Growth5 Y	1.3%
OCF Growth	43.01%
OCF Growth Q	-23.89%
OCF Growth10 Y	15.04%
OCF Growth3 Y	42.19%
OCF Growth5 Y	15.43%
Revenue Growth	21.54x
Revenue Growth Q	15.2x
Revenue Growth Quarters	14x
Revenue Growth Years	5x
Revenue Growth3 Y	21.3x
Revenue Growth5 Y	19.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.76
Assets	TWD 7.8B
Cash	TWD 662.8M
Current Assets	TWD 4.3B
Current Liabilities	TWD 2.5B
Debt	TWD 2.1B
Debt EBITDA	TWD 1.62
Debt Equity	TWD 0.49
Debt FCF	TWD 6.08
Equity	TWD 4.2B
Interest Coverage	16.12
Liabilities	TWD 3.6B
Long Term Assets	TWD 3.5B
Long Term Liabilities	TWD 1.1B
Net Cash	TWD -1.4B
Net Cash By Market Cap	TWD -14.51
Net Debt EBITDA	TWD 1.13
Net Debt Equity	TWD 0.33
Net Debt FCF	TWD 4.12
Tangible Book Value	TWD 3.6B
Tangible Book Value Per Share	TWD 37.79
WACC	5.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.72
Inventory Turnover	0.64
Net Working Capital	TWD 2.2B
Quick ratio	0.83
Working Capital	TWD 1.8B
Working Capital Turnover	TWD 3.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.41%
Dividend Growth	-0.07%
Dividend Growth Years	0%
Dividend per share	TWD 4.5
Dividend Years	3
Dividend Yield	4.51%
Ex Div Date	2025-07-23
Last Dividend	TWD 4
Payout Frequency	Annual
Payout Ratio	68.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	82.78%
1Y total return	21.25%
200-day SMA	111.6
3Y total return	80.6%
50-day SMA	104
50-day SMA vs 200-day SMA	50under200
5Y total return	226.77%
All Time High	131.5
All Time High Change	-24.18%
All Time High Date	2025-11-03
All Time Low	7.79
All Time Low Change	1,179.19%
All Time Low Date	2004-10-25
ATR	2.24
Beta	0.43
Beta1y	0.22
Beta2y	0.22
Ch YTD	-10.98
High	101
High52	131.5
High52 Date	2025-11-07
High52ch	-24.18%
Low	98.1
Low52	93.4
Low52 Date	2025-05-08
Low52ch	16.88%
Ma50ch	-4.16%
Price vs 200-day SMA	-10.68%
RSI	43.41
RSI Monthly	50.98
RSI Weekly	41.93
Sharpe ratio	0.55x
Sortino ratio	1.09
Total Return	0.1%
Tr YTD	-10.98
Tr15y	178.92%
Tr1m	0.61%
Tr1w	0.4%
Tr3m	-8.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 740.7M
Operating Income Growth	21.63
Operating Income Growth Q	8.15
Operating Income Growth3 Y	29.44
Operating Income Growth5 Y	52.48
Operating margin	13.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	78,592,417%
Net Borrowing	181,467,000
Shares Insiders	9.45%
Shares Institutions	5.62%
Shares Out	96,437,000
Shares Qo Q	0.1%
Shares Yo Y	4.41%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 338.7M
Average Volume	247,656.85x
Bv Per Share	42.51
CAPEX	TWD -687.1M
Ch10y	37.14
Ch15y	86.36
Ch1m	0.61
Ch1w	0.4
Ch1y	16.61
Ch20y	724
Ch3m	-8.95
Ch3y	61.85
Ch5y	184.9
Ch6m	-22.41
Change	1.63%
Change From Open	1.63
Close	98.1
Days Gap	0
Depreciation Amortization	493,694,000
Dollar Volume	20,528,728.5
Earnings Date	2026-05-15
EBIT	TWD 740.7M
EBITDA	TWD 1.2B
EPS	TWD 5.67
F Score	6
FCF	TWD 338.7M
FCF EV Yield	3.05x
FCF Per Share	TWD 3.51
Financing CF	-238,231,000
Fiscal Year End	December
Founded	1,993
Goodwill	297,715,000
Graham Number	73.64248
Graham Upside	-26.14
Income Tax	TWD 184.9M
Investing CF	-714,922,000
Is Primary Listing	1
Last Earnings Date	2025-11-10
Last Report Date	2025-12-31
Lynch Fair Value	TWD 142
Lynch Upside	42.18
Ma150	112.7
Ma150ch	-11.54%
Ma20	101.7
Ma20ch	-1.99%
Net CF	52,127,000
Next Earnings Date	2026-05-15
Open	98.1
P FCF Ratio	28.39
P OCF Ratio	9.37
Payment Date	2025-08-20
Position In Range	55.17
Ppne	2,172,963,000
Price Date	2026-05-08
Price EBITDA	TWD 7.79
Ptbv Ratio	2.64
Relative Volume	0.78x
Revenue	5,655,418,000x
Tax By Revenue	3.27x
Tax Rate	24.45%
Tr20y	1,252.55%
Tr6m	-22.41%
Volume	205,905
Z Score	3.15

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/4129 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.5%

$4.50 annual per share

Payout ratio

+68.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+36.7%

0 consecutive years of growth

Total shareholder yield

+0.1%

Next ex-dividend date: 2025-07-23

Performance

TPEX/4129 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4129?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.6%

Share of float held by funds and institutions

Insider ownership

+9.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.4%

Negative means the company is buying back shares.

Technical

TPEX/4129 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.4

Neutral momentum band

Price vs 200-day MA

-10.7%

50/200-day relationship not available

Beta (5Y)

0.43

Less volatile than the market

Sharpe ratio

0.55

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4129

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4129 stock rating?

tpex/4129 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4129 analysis?

The full report lives at /stocks/tpex/4129/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4129?

The latest report frames tpex/4129 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4129 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.